CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 133 filers reported holding CYTOKINETICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,211,474 | -42.6% | 176,900 | -36.5% | 0.01% | -43.5% |
Q2 2023 | $9,081,408 | -43.5% | 278,400 | -39.1% | 0.02% | -43.9% |
Q1 2023 | $16,081,830 | -22.9% | 457,000 | +0.4% | 0.04% | -29.3% |
Q4 2022 | $20,848,100 | +7.1% | 455,000 | +13.2% | 0.06% | +3.6% |
Q3 2022 | $19,472,000 | +6.7% | 401,900 | -13.5% | 0.06% | +7.7% |
Q2 2022 | $18,246,000 | -14.4% | 464,400 | -19.8% | 0.05% | -8.8% |
Q1 2022 | $21,324,000 | -40.0% | 579,300 | -25.6% | 0.06% | -36.0% |
Q4 2021 | $35,511,000 | +21.2% | 779,100 | -5.0% | 0.09% | +17.1% |
Q3 2021 | $29,303,000 | +68.8% | 819,900 | -6.5% | 0.08% | +65.2% |
Q2 2021 | $17,356,000 | -23.5% | 877,000 | -10.1% | 0.05% | -25.8% |
Q1 2021 | $22,685,000 | +44.8% | 975,300 | +29.3% | 0.06% | +47.6% |
Q4 2020 | $15,670,000 | -9.2% | 754,100 | -5.4% | 0.04% | -14.3% |
Q3 2020 | $17,266,000 | +0.7% | 797,500 | +9.7% | 0.05% | -2.0% |
Q2 2020 | $17,140,000 | +115.8% | 727,200 | +7.9% | 0.05% | +66.7% |
Q1 2020 | $7,944,000 | +43.8% | 673,800 | +29.4% | 0.03% | +130.8% |
Q4 2019 | $5,526,000 | +79.3% | 520,800 | +92.3% | 0.01% | +62.5% |
Q3 2019 | $3,082,000 | +6.8% | 270,800 | +5.6% | 0.01% | +14.3% |
Q2 2019 | $2,886,000 | +53.5% | 256,500 | +10.4% | 0.01% | +40.0% |
Q1 2019 | $1,880,000 | +366.5% | 232,400 | +264.8% | 0.01% | +400.0% |
Q4 2018 | $403,000 | -38.8% | 63,700 | -4.8% | 0.00% | -50.0% |
Q3 2018 | $659,000 | +1.1% | 66,900 | -14.9% | 0.00% | 0.0% |
Q2 2018 | $652,000 | +7.8% | 78,600 | -6.4% | 0.00% | 0.0% |
Q1 2018 | $605,000 | -0.8% | 84,000 | +12.3% | 0.00% | 0.0% |
Q4 2017 | $610,000 | -8.5% | 74,800 | +62.6% | 0.00% | 0.0% |
Q3 2017 | $667,000 | +46.3% | 46,000 | +22.0% | 0.00% | 0.0% |
Q2 2017 | $456,000 | -12.3% | 37,700 | -6.9% | 0.00% | 0.0% |
Q1 2017 | $520,000 | -13.3% | 40,500 | -18.0% | 0.00% | 0.0% |
Q4 2016 | $600,000 | -27.1% | 49,400 | -44.9% | 0.00% | -50.0% |
Q3 2016 | $823,000 | +97.4% | 89,700 | +104.3% | 0.00% | +100.0% |
Q2 2016 | $417,000 | -12.0% | 43,900 | -34.7% | 0.00% | -33.3% |
Q1 2016 | $474,000 | -42.3% | 67,200 | -14.5% | 0.00% | -40.0% |
Q4 2015 | $822,000 | +914.8% | 78,595 | +549.4% | 0.01% | +400.0% |
Q3 2015 | $81,000 | – | 12,102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 325,000 | $6,754,000 | 6.26% |
RP Management, LLC | 875,656 | $18,196,000 | 5.58% |
BVF INC/IL | 4,878,035 | $101,366,000 | 3.99% |
Burrage Capital Management LLC | 246,036 | $5,113,000 | 3.90% |
Integral Health Asset Management, LLC | 525,000 | $10,910,000 | 3.24% |
Foresite Capital Management IV, LLC | 1,435,992 | $29,840,000 | 3.24% |
Opaleye Management Inc. | 582,800 | $12,111,000 | 1.58% |
Boxer Capital, LLC | 2,100,000 | $43,638,000 | 1.40% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 3,226,567 | $67,048,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,461,000 | $51,140,000 | 1.01% |